ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

National Policy: IOM Seeks Nominations for Cancer Policy Board

November 29, 1996

Consensus Growing On Prevention Strategies: Higginson

August 14, 1981

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer

August 27, 2004

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990